Lisa Durette

I’m a passionate teacher, clinician, and advocate for child and adolescent psychiatry. In 2013, I spearheaded
southern Nevada’s first child & adolescent psychiatry (CAP) fellowship program, and have continued to serve
as its Program Director. In this role, I create and facilitate a weekly cross-educational didactic program which
includes problem-based learning, collaborative case consultation with UNLV’s Psychology Doctoral Program
(shared case conference for 3+ years), family systems therapy with emerita faculty and journal club. In
addition, I initiated the implementation of a collaborative care case discussion curriculum between residents
from pediatrics and our CAP fellows.
My impact on the child psychiatry community in NV and nationally has been significant. Nevada ranks 51st for
children’s mental health metrics ( Our fellowship’s mission is to build southern Nevada’s
CAP workforce. To date, 100% of graduates practice CAP in southern NV and two of them teach for the
program. My efforts to expand access to child psychiatry in Nevada are also reflected in my grant-funded work,
the Pediatric Access Line. The PAL is a statewide child psychiatry access program, and is a clinical experience
in which senior CAP fellows learn invaluable skills of collaborative care. To date, we’ve conducted over 300
primary care clinical consultations, and over 1,400 care coordination encounters. I also directly supervise
fellows rotating through Mojave Counseling, and individually supervise fellows I do not directly supervise
in-clinic. I’ve won an Excellence in Fellow Mentoring award from the CAP fellows.
I also teach child psychiatry curriculum to general psychiatry and pediatrics residents. I’ve taught for the
medical school and currently mentor two medical students’ research projects, one of which is a retrospective
chart review of psychotropic prescribing practices in a community clinic treating foster care involved youth, and
the other is analyzing data pre- and post-initiation of the child psychiatry access program’s questionnaire of
primary care clinicians’ experiences working with youth mental health concerns. Both projects’ databases are
complete and we are actively analyzing our outcomes for publication, in which the medical students have a key
role in both background research and writing.

Jeffrey Ebersole

Dr. Ebersole received a BA in Biology from Temple University and a PhD in Microbiology from the University of Pittsburgh. He then did a postdoctoral fellowship in the Department of Immunology at The Forsyth Institute and remained on the faculty at Forsyth and Harvard School of Dental Medicine until 1985. From 1985-2000 he was a Professor in the Department of Periodontics and Microbiology at the University of Texas Health Science Center at San Antonio. From 2000-2017 he was the Alvin L. Morris Professor of Oral Health Research, Director of the Center for Oral Health Research and Associate Dean for Research in the College of Dentistry at the Univeristy of Kentucky. Since 2017 he has been a Professor of Biomedical Sciences and Associate Dean for Research at the University of Nevada Las Vegas School of Dental Medicine. In 1983 he received the IADR award for Basic Oral Science Research and in 2000 the IADR award for Basic Research in Periodontal Disease. He served as the President of the American Association for Dental Research in 2011-2012. He directed a major COBRE grant from the NIH supporting the Center for the Biologic Basis of Oral/Systemic Diseases at the Univeristy of Kentucky. His CV contains over 300 publications, reviews and book chapters in the microbiology and immunology of oral diseases.
Dr. Ebersole’s laboratory focuses its research efforts on the immunobiology of oral infections. The research emphasizes in vitro, and in vivo studies of host-pathogen interactions using animal and human models of oral disease(s). The COBRE center supported research projects extending over a range of oral-systemic disease studies, including HIV, pregnancy, gestational diabetes, cardiovascular disease, and inflammatory bowel disease, as well as genetic and environmental challenges that increase the risk of these diseases. The lab was also a part of a major NIDCR effort to identify and validate the potential for point-of-care salivary biomarkers as diagnostic tools for oral and systemic diseases. Research in this area with engineers at Rice University/University of Texas/NYU focused on salivary biomarkers of oral and systemic diseases.

Jason Flatt

I have experience conducting research with diverse Sexual and Gender Minorities (SGM) or lesbian, gay, bisexual, transgender, queer, intersex, asexual and another identity (LGBTQIA+) persons living with Alzheimer’s Disease and Related Dementias (ADRD) and their caregivers. My research involving SGM older adults and caregivers has helped to enhance understanding of ADRD risk and disparities, long-term care and related healthcare needs, workforce challenges, and potential solutions. I am currently Co-PI (Anderson, Flatt, Wharton; NIA R24AG066599 ) on The RISE (Research Inclusion Supports Equity) Registry. This registry is the first effort to recruit, engage, and retain SGM older adults with ADRD and SGM ADRD caregivers. I am also lead PI of a new 5-year grant to develop more inclusive measures of caregiving for SGM older adults living with ADRD. I am also in the final year of my Career Award (NIA K01AG056669), “The Epidemiology of Alzheimer’s Disease and Related Dementias in Sexual and Gender Minority Older Adults: Identifying Risk and Protective Factors.” I also received the 2020 Early-Stage Investigator Award from the NIH Sexual and Gender Minority Research Office for this research. My research research has also been funded by American Federation for Aging Research, the Alzheimer’s Association, and The Michael J. Fox Foundation for Parkinson’s Research.

M. Rashed Khan

Khan Lab@UNR aims to study, design, and develop soft materials, unconventional processes, and reconfigurable micro/nanodevices that can be harnessed and optimized further for advanced biochemical, biomedical, and physicochemical applications. The lab is also keen to establish a multidisciplinary smart-manufacturing research group, including researchers from various backgrounds. Through short and long-term active collaboration, Khan Lab@UNR would like to address fundamental challenges associated with soft micro-device fabrication, 3D/4D (bio)printing, and patterning, advanced hybrid sensor manufacturing, biomedical device development – which are still unnoticed and under-explored, and need further investigation.

Additionally, our group also focuses on computational neuroscience and neurobioengineering. Under this research direction, we study human brain, brain functions, brain structure so that the established knowledge can be broadly applicable to general biomecical science and knowledge of the brain and brain-diseases.

Edwin Oh

We are a research group that thrives on collaboration. Through our interactions with collaborators, public health labs, and patients we have developed a research program that interrogates the following themes:

1) Wastewater genomics and COVID-19

Wastewater testing has been used for years to investigate viral infections, to study illicit drug use, and to understand the socioeconomic status of a community based on its food consumption. While tools are in place in many states to evaluate the presence of specific viral strains, the community has not needed previously to collaborate on a global scale to standardize procedures to detect and manage COVID-19 transmission. In response to this challenge, our laboratories in Arizona, Nevada, and Washington have developed collection techniques and genomic and bioinformatic approaches to harmonize and visualize the impact of SARS-CoV-2 infection and viral mutation rates in communities populated by local citizens and international tourists. Our findings will contribute to the development of best practices in sampling and processing of wastewater samples and genomic techniques to sequence viral strains, an area required for environmental surveillance of infectious diseases, and has the strong potential to improve the clinically predictive impact of the viral genotype on patient care and vaccine utility.

2) Rare neurological conditions

An association between the 16p13.2 copy number variation deletion and seizures has suggested that a) systematic suppression of each of genes in the loci might yield similar neurological phenotypes seen in the 16p13.2 deletion; and b) such genes might be strong candidates for harboring rare pathogenic point mutations. Through these studies, we discovered USP7 as a message capable of inducing abnormal neurological activity in brain organoids, cultured neurons, and loss-of-function mouse models. Together with collaborators at the Foundation for USP7-Related Diseases (, our studies are centered on the mechanism by which USP7 gene dosage and rare variants can induce pathology. In addition, we have also identified other gene loci that mimic USP7-related disorders in human and animal models.

3) Ciliary biology and neurodevelopmental conditions

Large-scale studies have begun to map the genetic architecture of Schizophrenia. We now know that the genetic contribution to this condition arises from a variety of lesions that include a) rare copy number variants (CNVs) of strong effect; b) common non-coding alleles of mild effect; and c) rare coding alleles that cluster in biological modules. The challenge that has emerged from these studies is the requirement for large sample sizes to detect significant genetic signals. These findings intimate that SZ is genetically heterogeneous and manifesting potentially as a clinically heterogeneous group of phenotypes with discrete physiological drivers. To address this challenge and to complement the ongoing sequencing effort of cross-sectional SZ, we propose to sample individuals with extreme phenotypes (i.e., resistant to treatment: TRS) to potentially discover an enrichment of causal rare variants which would have otherwise not been observed or been difficult to detect in a large, random sampling of SZ. In addition, we will focus on the role of a specific biological module, the pericentriolar material (including the centrosome, basal body, and primary cilium) and how it relates to the development of the brain and behavior through the genomic and functional dissection of PCM1.